Involvement of pulmonary endothelial cell injury in the pathogenesis of pulmonary fibrosis: clinical assessment by 123I-MIBG lung scintigraphy

[1]  T. King,et al.  Idiopathic Interstitial Pneumonias , 2010 .

[2]  D. Slosman,et al.  123I-MIBG pulmonary removal: a biochemical marker of minimal lung endothelial cell lesions , 2005, European Journal of Nuclear Medicine.

[3]  P. Alderson,et al.  131I-metaiodobenzylguanidine and 125I-iodoamphetamine , 1989, European Journal of Nuclear Medicine.

[4]  D. Slosman,et al.  Lung uptake of 131I-metaiodobenzylguanidine in sheep , 1988, European Journal of Nuclear Medicine.

[5]  A. Brill,et al.  131I-metaiodobenzylguanidine uptake in the isolated rat lung: A potential marker of endothelial cell function , 2004, European Journal of Nuclear Medicine.

[6]  R. D. du Bois,et al.  Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis. , 2003, Chest.

[7]  I. Kubota,et al.  In vivo evidence of endothelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of (123)I-metaiodobenzylguanidine. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  B. Ballermann,et al.  Endothelial cell apoptosis during glomerular capillary lumen formation in vivo. , 2003, Journal of the American Society of Nephrology : JASN.

[9]  A. Nicholson,et al.  Interstitial vascularity in fibrosing alveolitis. , 2003, American journal of respiratory and critical care medicine.

[10]  H. Mukae,et al.  High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia , 2003, Thorax.

[11]  D. Knight,et al.  The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma. , 2003, American journal of clinical pathology.

[12]  F. Green.  Overview of pulmonary fibrosis. , 2002, Chest.

[13]  A. Galloway,et al.  Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase. , 2002, Surgery.

[14]  M. Haniuda,et al.  Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.

[15]  N. Kohno,et al.  Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. , 2002, American journal of respiratory and critical care medicine.

[16]  M. Ünlü,et al.  Pulmonary involvement in Behçet's disease: evaluation of 123I-MIBG retention , 2001, Nuclear medicine communications.

[17]  T. Nishimura,et al.  Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure , 2001, Annals of nuclear medicine.

[18]  J. Lasky,et al.  Interstitial fibrosis and growth factors. , 2000, Environmental health perspectives.

[19]  J. Fujita,et al.  Circulating Cytokeratin 8:Anti-Cytokeratin 8 Antibody Immune Complexes in Sera of Patients with Pulmonary Fibrosis , 2000, Respiration.

[20]  M. Fujimoto,et al.  Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis , 2000, Clinical and experimental immunology.

[21]  Arnold Simanowitz,et al.  international consensus statement , 2000 .

[22]  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). , 2000, American journal of respiratory and critical care medicine.

[23]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[24]  R. Ueda,et al.  Elevation of Anti-Cytokeratin 18 Antibody and Circulating Cytokeratin 18: Anti-Cytokeratin 18 Antibody Immune Complexes in Sera of Patients with Idiopathic Pulmonary Fibrosis , 2000, Lung.

[25]  E. Hoffman,et al.  Interstitial lung disease: A quantitative study using the adaptive multiple feature method. , 1999, American journal of respiratory and critical care medicine.

[26]  Y. Takeishi,et al.  Cardiac sympathetic nervous disintegrity is related to exercise intolerance in patients with chronic heart failure , 1998, Nuclear medicine communications.

[27]  T. Ichihara,et al.  Increased lung uptake of iodine-123-MIBG in diabetics with sympathetic nervous dysfunction. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  S. Inanır,et al.  Prolonged lung retention of iodine-123-MIBG in diabetic patients. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Y. Takeishi,et al.  ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  J. Bomanji,et al.  A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). , 1992, Nuclear medicine communications.

[31]  John F. Murray,et al.  Textbook of Respiratory Medicine , 1988 .

[32]  P. Alderson,et al.  A new imaging approach to quantitative evaluation of pulmonary vascular endothelial metabolism , 1988, Journal of thoracic imaging.

[33]  J. Sisson,et al.  Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  J. Lazo,et al.  Bleomycin inhibition of angiotensin-converting enzyme activity from serum, lungs, and cultured pulmonary artery endothelial cells. , 2015, The American review of respiratory disease.

[35]  J. Sisson,et al.  Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  C. N. Gillis,et al.  Pulmonary endothelial dysfunction in the presence or absence of interstitial injury induced by intratracheally injected bleomycin in rabbits. , 1983, The American review of respiratory disease.

[37]  Y Kasahara,et al.  Colorimetry of angiotensin-I converting enzyme activity in serum. , 1981, Clinical chemistry.

[38]  N. Clinthorne,et al.  Myocardial imaging with a radioiodinated norepinephrine storage analog. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  R. Good.  Disorders of the Immune System , 1967 .